Who are Blank maleate entecavir tablets's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): telbivudine (ROADMAP), Telbivudine, Lamivudine, Adefovir ,Enecavir, Baraclude tablets, Adefovir Dipivoxil Tablets, Adefor dipivoxil, Adefovir dipivoxil (adefovir).

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/blank-maleate-entecavir-tablets.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-17 · How we verify

Blank maleate entecavir tablets — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Blank maleate entecavir tablets (Blank maleate entecavir tablets) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Nucleoside reverse transcriptase inhibitor. Area: Virology / Hepatology.

marketed Nucleoside reverse transcriptase inhibitor Hepatitis B virus reverse transcriptase Virology / Hepatology Small molecule Live · refreshed every 30 min

Target snapshot

Blank maleate entecavir tablets (Blank maleate entecavir tablets) — Chia Tai Tianqing Pharmaceutical Group Co., Ltd.. Entecavir inhibits hepatitis B virus reverse transcriptase and protein priming, blocking viral DNA replication.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
Blank maleate entecavir tablets TARGET	Blank maleate entecavir tablets	Chia Tai Tianqing Pharmaceutical Group Co., Ltd.	marketed	Nucleoside reverse transcriptase inhibitor	Hepatitis B virus reverse transcriptase
telbivudine (ROADMAP)	telbivudine (ROADMAP)	Nanfang Hospital, Southern Medical University	marketed	Nucleoside reverse transcriptase inhibitor (NRTI)	Hepatitis B virus reverse transcriptase
Telbivudine, Lamivudine, Adefovir ,Enecavir	Telbivudine, Lamivudine, Adefovir ,Enecavir	Shao-quan Zhang	marketed	Nucleoside/nucleotide reverse transcriptase inhibitor (NRTI/NtRTI)	Hepatitis B virus reverse transcriptase
Baraclude tablets	Baraclude tablets	Chia Tai Tianqing Pharmaceutical Group Co., Ltd.	marketed	Nucleoside reverse transcriptase inhibitor (NRTI)	Hepatitis B virus reverse transcriptase / HBV polymerase
Adefovir Dipivoxil Tablets	Adefovir Dipivoxil Tablets	Sun Yat-sen University	marketed	Nucleotide reverse transcriptase inhibitor	Hepatitis B virus reverse transcriptase and DNA polymerase
Adefor dipivoxil	Adefor dipivoxil	GlaxoSmithKline	marketed	Nucleotide reverse transcriptase inhibitor	Hepatitis B virus reverse transcriptase
Adefovir dipivoxil (adefovir)	Adefovir dipivoxil (adefovir)	Merck Sharp & Dohme LLC	marketed	Nucleotide reverse transcriptase inhibitor	Hepatitis B virus reverse transcriptase / DNA polymerase

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Nucleoside reverse transcriptase inhibitor class)

Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · 1 drug in this class
Novartis · 1 drug in this class
University of Guadalajara · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Blank maleate entecavir tablets — Competitive Intelligence Brief. https://druglandscape.com/ci/blank-maleate-entecavir-tablets. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab